[Conclusions from the clinical trials of TachoComb, a hemostatic].
The authors present a report on their very favourable experience assembled during clinical tests of a new haemostatic TachoComb of the company HAFSLUND NYCOMED PHARMA AG Linz Austria which were made at their department before the preparation was introduced in the Czech Republic. Despite the high price the authors recommend that the preparation should be available in every operation theatre in particular for haemostasis of injured parenchymatous organs.
Vykouril
L
L
Vojenská lékarská akademie J.E. Purkynĕ, Hradec, Králové.
Bedrna
J
J
D000328:Adult; D000368:Aged; D007611:Aprotinin; D002986:Clinical Trials as Topic; D004338:Drug Combinations; D005260:Female; D005340:Fibrinogen; D006488:Hemostasis, Surgical; D006490:Hemostatics; D006801:Humans; D008297:Male; D008875:Middle Aged; D013917:Thrombin
D004338:Drug Combinations; D006490:Hemostatics; C093991:tachocomb; D005340:Fibrinogen; D007611:Aprotinin; D013917:Thrombin
Závĕry z klinických zkousek hemostyptika TachoComb.